Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 05 - 09 tags : Biotech-beach save search
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
Published: 2022-05-09 (Crawled : 21:00) - biospace.com/
TAK | News | $13.36 0.91% 0.0% 1.5M
|
Health Technology
|
| O: -0.69%
H: 0.28%
C: -1.1%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
ARCT 4 | $27.06 4.16% 4.03% 330K
|
Health Technology
|
| O: -2.88%
H: 2.34%
C: -8.64%
therapeutics
Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates
Published: 2022-05-09 (Crawled : 21:00) - biospace.com/
HRTX M | $2.59 -1.89% -2.13% 2.1M
|
Health Technology
|
| O: -1.7%
H: 1.36%
C: -10.64%
therapeutics
Inhibrx Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
Published: 2022-05-09 (Crawled : 21:00) - biospace.com/
INBX | $34.1 -0.64% -0.5% 470K
|
Health Technology
|
| O: -3.66%
H: 6.6%
C: -2.67%
results
Therapeutic Solutions International Files Investigational New Drug Application for Treatment of Chronic Obstructive Pulmonary Disease (COPD) Using JadiCell™ Universal Donor Adult Stem Cells
Published: 2022-05-09 (Crawled : 14:00) - biospace.com/
TSOI | $0.0007 0.0% 23M
|
Manufacturing
|
| O: -2.43%
H: 3.73%
C: 1.66%
treatment drug disease solutions application international
Eledon Pharmaceuticals Announces First Patient Dosed in Phase 2a Trial Evaluating Tegoprubart in IgA Nephropathy
Published: 2022-05-09 (Crawled : 13:00) - biospace.com/
ELDN | $2.02 8.6% 7.46% 310K
|
Manufacturing
|
| O: 0.71%
H: 0.18%
C: -12.63%
nephropathy trial phase 2b
NovaBay Pharmaceuticals Expands Top-Selling DERMAdoctor Kakadu C and Calm Cool + Corrected Collections with New Anti-Aging Formulations
Published: 2022-05-09 (Crawled : 12:00) - biospace.com/
NBY | $0.0725 -12.02% -0.83% 4M
|
Health Technology
|
| O: 1.32%
H: 2.47%
C: -9.64%
MannKind Corporation Participating at Upcoming Conferences - May 09, 2022
Published: 2022-05-09 (Crawled : 11:00) - biospace.com/
MNKD | $4.11 -1.68% -1.46% 1.8M
|
Health Technology
|
| O: 0.34%
H: 2.78%
C: -4.81%
corporation
RadNet Reports First Quarter Financial Results with Record Revenue and Adjusted EBITDA(1) from Imaging Center Operations and Revises Upwards 2022 Financial Guidance Ranges
Published: 2022-05-09 (Crawled : 11:00) - biospace.com/
RDNT | News | $47.65 2.43% 2.29% 360K
|
Health Services
|
| O: -7.11%
H: 5.56%
C: 0.06%
imaging results
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.